Schrodinger Starts U.S. IPO Effort With $100 Million Filing

|
About: Schrödinger (SDGR), Includes: CGEN, DASTY
by: Donovan Jones
This article is exclusive for subscribers.
Donovan Jones
IPOs, tech, alternative investments, CEO VentureDeal.com
Summary

Schrodinger has filed to raise $100 million (placeholder figure) in an IPO.

The firm sells drug discovery software and uses its platform for internal discovery programs as well.

SDGR is growing well but producing ever-increasing operating losses.

Quick Take

Schrödinger (SDGR) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.

The firm sells drug and compound discovery software to